Frank Takkinen
Stock Analyst at Lake Street
(1.81)
# 3,296
Out of 5,124 analysts
71
Total ratings
35.38%
Success rate
-9.71%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRMD KORU Medical Systems | Maintains: Buy | $6 → $8 | $5.58 | +43.37% | 3 | Dec 22, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $7.47 | +60.64% | 7 | Dec 10, 2025 | |
| AXGN Axogen | Maintains: Buy | $30 → $40 | $31.05 | +28.82% | 2 | Dec 4, 2025 | |
| NOTV Inotiv | Maintains: Buy | $5 → $3 | $0.64 | +367.00% | 8 | Dec 4, 2025 | |
| ADGM Adagio Medical Holdings | Initiates: Buy | $4 | $0.99 | +303.67% | 1 | Dec 2, 2025 | |
| TELA TELA Bio | Maintains: Buy | $6 → $3 | $1.15 | +160.87% | 3 | Dec 1, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $8 → $4 | $2.33 | +71.67% | 3 | Oct 28, 2025 | |
| RCEL AVITA Medical | Downgrades: Hold | $8 → $4 | $3.42 | +16.96% | 1 | Oct 17, 2025 | |
| ELUT Elutia | Maintains: Buy | $8 → $6 | $0.63 | +855.41% | 4 | Sep 10, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.5 → $2 | $1.02 | +96.08% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $150 | $97.21 | +54.31% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $11.44 | +109.79% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $30 | $31.40 | -4.46% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $7.92 | +76.77% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $11.40 | +31.58% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $18.40 | +41.30% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $15.27 | +96.46% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.96 | +303.23% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.81 | +176.24% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $45.36 | -33.86% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.68 | +778.73% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.55 | +56.86% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $16.39 | -26.78% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.57 | +152.45% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $3.77 | +324.40% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $923 → $277 | $6.98 | +3,867.05% | 2 | Jan 18, 2023 |
KORU Medical Systems
Dec 22, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $5.58
Upside: +43.37%
Sight Sciences
Dec 10, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $7.47
Upside: +60.64%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $31.05
Upside: +28.82%
Inotiv
Dec 4, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.64
Upside: +367.00%
Adagio Medical Holdings
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $0.99
Upside: +303.67%
TELA Bio
Dec 1, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $1.15
Upside: +160.87%
Pulmonx
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $2.33
Upside: +71.67%
AVITA Medical
Oct 17, 2025
Downgrades: Hold
Price Target: $8 → $4
Current: $3.42
Upside: +16.96%
Elutia
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.63
Upside: +855.41%
Hyperfine
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.02
Upside: +96.08%
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $97.21
Upside: +54.31%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $11.44
Upside: +109.79%
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $31.40
Upside: -4.46%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $7.92
Upside: +76.77%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $11.40
Upside: +31.58%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $18.40
Upside: +41.30%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $15.27
Upside: +96.46%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $4.96
Upside: +303.23%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.81
Upside: +176.24%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $45.36
Upside: -33.86%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.68
Upside: +778.73%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.55
Upside: +56.86%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $16.39
Upside: -26.78%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.57
Upside: +152.45%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $3.77
Upside: +324.40%
Jan 18, 2023
Maintains: Buy
Price Target: $923 → $277
Current: $6.98
Upside: +3,867.05%